Liver Cancer
📧 Sign up to get email alerts when something new happens for Liver Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-13Clinical Trial Update: Safety and Efficiency of γδ T Cell Against Liver Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating safety and efficacy of γδ T cell therapy for liver cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2020-04-16Clinical Trial Update: Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy [Phase 2, Phase 3]
Phase 2/3 trial evaluating autologous immune killer cells as an adjunct therapy for liver cancer (hepatocellular carcinoma).
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer [Phase 2]
Phase 2 trial evaluating Lipiodol as an imaging biomarker in patients with primary and metastatic liver cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis [Phase 3]
Phase 3 trial evaluating sorafenib tosylate with or without pravastatin in liver cancer with cirrhosis has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas [Phase 3]
Phase 3 trial comparing postoperative thoracic epidural analgesia to intravenous patient-controlled analgesia for liver and/or pancreatic ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver Cancer [Phase 2, Phase 3]
Clinical trial update for a GP96 heat shock protein-peptide complex vaccine being studied in liver cancer across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 [Phase 1, Phase 2]
Phase 1/2 trial evaluating CART133 for relapsed/chemo-refractory advanced malignancies completed, across multiple cancers.
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: Tremelimumab With Chemoembolization or Ablation for Liver Cancer [Phase 1, Phase 2]
Phase 1/2 trial exploring tremelimumab combined with chemoembolization or ablation for liver cancers has completed enrollment with results p…
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer [NA]
Clinical trial completion for SBRT in metastatic non-small cell lung cancer with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer [Phase 3]
Phase 3 clinical trial update evaluating combined immunotherapy and targeted therapy for advanced liver cancer.
-
CLINICAL_TRIALS trial_result · 2019-11-07Clinical Trial Update: Regeneration of Liver: Portal Vein Embolization Versus Radiofrequency Assisted Ligation for Liver Hypertrophy (REBIRTH) [NA]
Clinical trial comparing portal vein embolization to radiofrequency-assisted ligation for liver hypertrophy in patients undergoing liver res…
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment [Phase 3]
Phase 3 trial comparing brivanib with best supportive care to placebo in liver cancer patients after sorafenib failure has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery [Phase 2]
A Phase 2 trial comparing chemoembolization to radioembolization in liver cancer patients unsuitable for radiofrequency ablation or surgery …
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer [Phase 1, Phase 2]
Clinical trial updates the combination of cryosurgery and NK cell immunotherapy for advanced liver cancer, studied in Phase 1 and Phase 2 (c…
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer [Phase 1, Phase 2]
A combined Irreversible Electroporation and NK immunotherapy trial for recurrent liver carcinoma has completed Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure [Phase 3]
Phase 3 trial comparing parecoxib, celecoxib, and oxycodone for pain control after transcatheter chemoembolization in liver cancer patients …
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer [Phase 2]
Phase 2 trial assessing sorafenib with or without gemcitabine and oxaliplatin in locally advanced, unresectable, or metastatic liver cancer.
-
CLINICAL_TRIALS trial_result · 2019-05-31Clinical Trial Update: Celebrex and Metformin for Postoperative Hepatocellular Carcinoma [Phase 3]
Phase 3 clinical trial update investigating Celebrex (celecoxib) and Metformin for postoperative hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2019-05-22Clinical Trial Update: [18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer [Phase 2]
Phase 2 clinical trial evaluating [18F]FMISO PET/CT after transcatheter arterial embolization in adult liver cancer patients has completed w…
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer [Phase 2]
Phase 2 trial evaluating sorafenib tosylate with or without everolimus in localized, unresectable, or metastatic liver cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating CPI-613 in advanced or metastatic biliary tract cancers, including cholangiocarcinoma and unresectable o…
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating radiation therapy for unresectable liver cancer has completed.
-
CLINICAL_TRIALS research · 2019-04-23Clinical Trial Update: Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization [Phase 2]
Phase 2 clinical trial investigating an integrated imaging strategy to phenotype progression of liver tumors during and after chemoembolizat…
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers [Phase 3]
Phase 3 trial evaluating early palliative care added to standard care versus standard care alone in patients with incurable lung or non-colo…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L [Phase 3]
Phase 3 placebo-controlled clinical trial update for Hepcortespenlisimut-L in hepatocellular carcinoma (liver cancer).